Global Gouty Arthritis Market, By Diagnosis (Joint Fluid Test, Blood Test, X-Ray Imaging, Ultrasound, Dual Energy CT Scan, Others), Treatment (NSAIDs, Pain Reliever, Corticosteroids, Xanthine Oxidase Inhibitors, Uricosurics, Others), Route of Administration (Oral, Parenteral, Topical, Others), End-Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others) – Industry Trends and Forecast to 2029.
Gouty Arthritis Market Analysis and Size
The global gouty arthritis market is expected to witness significant growth during the forecast period. The growing acceptance of enhanced R&D on regeneration therapies, and rising incidence are the major drivers driving the gout therapeutics market. It typically affects men more than women and further damage to joints can be avoided by treatment. COVID-19 also had a major impact on the population and market growth.
Data Bridge Market Research analyses a growth rate in the global gouty arthritis market in the forecast period 2022-2029. The expected CAGR of global gouty arthritis market is tend to be around 6.50% in the mentioned forecast period. The market was valued at USD 3.0 billion in 2021, and it would grow upto USD 4.96 billion by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Definition
Gouty arthritis is a common and complex form of inflammatory arthritis that affects anyone. It is characterized by severe pain in joint especially in big toe joint, redness, swelling and tenderness in joint. Gouty arthritis developed due to the accumulation of uric acid in joint which causes pain and inflammation. If left untreated, this condition may damage joints or kidneys as excessive accumulation of uric acid crystals would lead to kidney stone or failure. In majority of cases, it is witnessed with other metabolic diseases or conditions such as obesity, hypertension, and diabetes.
Gouty Arthritis Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
By Diagnosis (Joint Fluid Test, Blood Test, X-Ray Imaging, Ultrasound, Dual Energy CT Scan, Others), Treatment (NSAIDs, Pain Reliever, Corticosteroids, Xanthine Oxidase Inhibitors, Uricosurics, Others), Route of Administration (Oral, Parenteral, Topical, Others), End-Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Pfizer Inc. (U.S.), Abbvie Inc. (U.S.), Novartis AG (Switzerland), Amgen Inc. (U.S.), Boehringer Ingelheim International GmbH. (Germany), Samsung Bioepis. (South Korea), Merck & Co Inc. (U.S.), Sun Pharmaceutical Industries Ltd. (India), Teva Pharmaceuticals Industries Ltd. (Israel), AstraZeneca (U.K.), BioCryst Pharmaceuticals, Inc. (U.S.), JW Pharmaceutical (South Korea), Addex Therapeutics (Switzerland)
|
|
Market Opportunities
|
|
Global Gouty Arthritis Market Dynamics
Drivers
- High Prevalence of Chronic Diseases
According to a 2014 study published in the Journal of Rheumatology, about 75% of patients with gouty arthritis have high blood pressure. Therefore, patients suffering from chronic illness are at increased risk of developing gouty arthritis. The high prevalence of gouty arthritis is expected to drive the growth of the global gouty arthritis market.
- Increased alcohol intake
Increased alcohol consumption is expected to drive the expansion of the gouty arthritis market during the forecast period as a result of the association between increased gout incidence and alcohol consumption and gout.
Opportunities
- Increase in Elderly Population
Life expectancy is growing around the world, which has led to an increase in the aging population. This trend positively impacts the industry by increasing the incidence of the disease and creating per capita demand for its remedies.
Restraints/Challenges
- Lack of skilled professionals
The lack of qualified personnel who are unable to perform the treatments could curb the growth of the global gouty arthritis market over a forecast period.
- High Cost
The huge expenditure required for treatment process surely hamper the market growth.
This global gouty arthritis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global gouty arthritis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Gouty Arthritis Market Scope
The global gouty arthritis market is segmented on the basis of diagnosis, treatment, route of administration, end-user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Diagnosis
- Joint Fluid Test
- Blood Test
- X-Ray Imaging
- Ultrasound
- Dual Energy CT Scan
- Others
Treatment
- NSAIDs
- Pain Reliever
- Corticosteroids
- Xanthine Oxidase Inhibitors
- Uricosurics
- Others
Route of Administration
- Oral
- Parenteral
- Topical
- Others
End-Users
- Hospitals
- Specialty Clinics
- Others
Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Others
Gouty Arthritis Market Regional Analysis/Insights
The global gouty arthritis market is analysed and market size insights and trends are provided by diagnosis, treatment, route of administration, end-user and distribution channel as referenced above.
The major countries covered in the global gouty arthritis market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the market due to increased prevalence of joint disease, and technological advancements in early diagnosis of the disease.
Asia-Pacific is expected to grow during forecast period due to increased joint replacement surgeries, increased awareness for joint disorders through advertisement & media and rapidly improving health care infrastructure in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Gouty Arthritis Market Share Analysis
The global gouty arthritis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global gouty arthritis market
Key players operating in the global gouty arthritis market include:
- Pfizer Inc. (U.S.)
- Abbvie Inc. (U.S.)
- Novartis AG (Switzerland)
- Amgen Inc. (U.S.)
- Boehringer Ingelheim International GmbH. (Germany)
- Samsung Bioepis. (South Korea)
- Merck & Co Inc. (U.S.)
- Sun Pharmaceutical Industries Ltd. (India)
- Teva Pharmaceuticals Industries Ltd. (Israel)
- AstraZeneca PLC (U.K.)
- BioCryst Pharmaceuticals, Inc. (U.S.)
- JW Pharmaceutical Corporation (South Korea)
- Addex Therapeutics (Switzerland)
SKU-